Literature DB >> 1733628

In vivo activation of complement by IgA in a rat model.

R K Stad1, W M Bogers, M E Thoomes-van der Sluys, L A Van Es, M R Daha.   

Abstract

In this study we investigated the capacity of rat IgA to activate complement (C) in vivo in a rat model. Rat monomeric (m-), dimeric (d-) and polymeric (p-) IgA MoAbs were injected intravenously and assessed for deposition of C3 and C4 on IgA. By ELISA it was shown that both d- and p-IgA bound C3 whereas no binding of C3 by m-IgA was observed. Polymeric IgA was more efficient in binding of C3 as compared with d-IgA. However, in haemolytic assays no consistent decrease of plasma complement levels was observed except for dimeric IgA which induced a marginal consumption of AP50. When rats were pre-treated with cobra venom factor (CVF) to deplete C3, no C3 deposition was found on m-, d- or p-IgA. Neither m- nor d- or p-IgA was able to bind C4 in vivo. In agreement with the results described above, large sized polymeric IgA was shown to be taken up by Kupffer cells (KC) together with C3. No C3 was detected when rats were depleted of C using CVF. Taken together, the experimental data suggest that d- and p-IgA are able to activate C via the alternative pathway in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733628      PMCID: PMC1554236          DOI: 10.1111/j.1365-2249.1992.tb06427.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Complement enhances the clearance of large-sized soluble IgA aggregates in rats.

Authors:  W M Bogers; R K Stad; D J Janssen; M Rits; H Bazin; L A Van Es; M R Daha
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

2.  The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.

Authors:  Y M Lucisano Valim; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

3.  Aminomethyl coumarin acetic acid: a new fluorescent labelling agent for proteins.

Authors:  H Khalfan; R Abuknesha; M Rand-Weaver; R G Price; D Robinson
Journal:  Histochem J       Date:  1986-09

4.  Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis.

Authors:  D J Evans; D G Williams; D K Peters; J G Sissons; J M Boulton-Jones; C S Ogg; J S Cameron; B I Hoffbrand
Journal:  Br Med J       Date:  1973-08-11

5.  IgA glomerular deposits in renal disease.

Authors:  J Berger
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

6.  Lack of complement activation by human IgA immune complexes.

Authors:  H Imai; A Chen; R J Wyatt; A Rifai
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

7.  A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.

Authors:  T A Gaither; D W Alling; M M Frank
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

8.  Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family.

Authors:  J J Roord; M Daha; W Kuis; H A Verbrugh; J Verhoef; B J Zegers; J W Stoop
Journal:  Pediatrics       Date:  1983-01       Impact factor: 7.124

9.  Activation of rat complement by soluble and insoluble rat IgA immune complexes.

Authors:  M Rits; P S Hiemstra; H Bazin; L A Van Es; J P Vaerman; M R Daha
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

10.  Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.

Authors:  G Pfaffenbach; M E Lamm; I Gigli
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  7 in total

1.  Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.

Authors:  W Zhang; P J Lachmann
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

2.  Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA.

Authors:  Yusuke Okubo; Kotaro Nochioka; Hiroshi Sakakibara; Hiroshi Hataya; Toshiro Terakawa; Marcia Testa; Robert P Sundel
Journal:  Clin Rheumatol       Date:  2016-09-05       Impact factor: 2.980

Review 3.  Oral microbial ecology and the role of salivary immunoglobulin A.

Authors:  H Marcotte; M C Lavoie
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

Review 4.  Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don't Know.

Authors:  Yukako Ohyama; Matthew B Renfrow; Jan Novak; Kazuo Takahashi
Journal:  J Clin Med       Date:  2021-08-05       Impact factor: 4.241

5.  Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers.

Authors:  H Dauchel; P Joly; A Delpech; E Thomine; F Sauger; X Le Loet; P Lauret; F Tron; M Fontaine; J Ripoche
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

6.  An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies.

Authors:  R K Stad; J A Bruijn; D J van Gijlswijk-Janssen; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

7.  Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.

Authors:  Kenji Satake; Yoshio Shimizu; Yohei Sasaki; Hiroyuki Yanagawa; Hitoshi Suzuki; Yusuke Suzuki; Satoshi Horikoshi; Shinichiro Honda; Kazuko Shibuya; Akira Shibuya; Yasuhiko Tomino
Journal:  BMC Nephrol       Date:  2014-06-13       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.